| 摘要: |
| 新型冠状病毒引起的新型冠状病毒感染(Coronavirus Disease-2019，COVID-19)在全球流行爆发，严重威胁人类生命健康，给全球造成了巨大的医疗、经济和社会破坏。重症COVID-19患者病死率高，目前无特效治疗药物，现有的药物治疗主要是通过抑制病毒复制、抗炎及免疫调节等机制起效。对于COVID-19患者，早期使用合适、有效的治疗药物会降低住院率及死亡率，并降低医疗成本，减轻医务人员负担。本文对重症COVID-19患者治疗药物的研究进行综述，拟为临床救治COVID-19患者的药物选择提供参考。 |
| 关键词: 新型冠状病毒 COVID-19 重症 治疗 药物开发 |
| DOI：10.13656/j.cnki.gxkx.20230710.003 |
| 投稿时间：2023-04-09修订日期：2023-05-29 |
| 基金项目:广西重点研发计划项目“新型冠状病毒感染的肺炎重症病例免疫微环境调控及ECMO新技术救治效果评价”(桂科AB20058002)资助。 |
|
| Research Progress in Drug Treatment for Severe Coronavirus Disease-2019 |
|
WEI Shanshan, ZHANG Jianfeng
|
| (The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China) |
| Abstract: |
| Coronavirus Disease-2019 (COVID-19,referred to a novel coronavirus pneumonia) caused by the novel coronavirus infection has broken out in the world,which seriously threatens human life and health,and has caused huge medical,economic and social damage to the world.The fatality rate of patients with severe COVID-19 is high.At present,there is no specific therapeutic drug.The existing drug treatment mainly works by inhibiting viral replication,anti-inflammatory and immunomodulatory mechanisms.For patients with COVID-19,early use of appropriate and effective therapeutic drugs will reduce hospitalization rates and mortality,reduce medical costs,and reduce the burden on medical staff.This article reviews the research on therapeutic drugs for patients with severe COVID-19,and intends to provide a reference for the selection of drugs for clinical treatment of patients with COVID-19. |
| Key words: novel coronavirus COVID-19 severe cases treatment drug development |
